top of page
Starting August 1, 2024, Quickarrays Inc. will be taking over Pantomics Inc. to
provide all products and services. Please visit Quickarrays Inc. for more information.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
Hermatopathology
OVC1021
Ovary cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases) tissues with grading and TNM staging data.
Price per slide:
$289
Species:
Human
Cases:
102
Cores:
102
Core Size:
1.5mm
Core Thickness:
4um
Rows:
8
Columns:
13
Format:
Intended Usage:
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in ovary cancers.
8
X
13
For illustration purpose only. Actual product may vary.
Notes:
All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.
Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | NATURE | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|---|
A01 |  | F | 37 | Ovary | Normal | Normal | ||
A02 |  | F | 31 | Ovary | Normal | Normal | ||
A03 |  | F | 50 | Ovary | Serous cystadenoma | Benign | ||
A04 |  | F | 22 | Ovary | Mucinous cystadenoma | Benign | ||
A05 |  | F | 37 | Ovary | Borderline mixed cystadenoma | Benign | ||
A06 |  | F | 48 | Ovary | Clear cell carcinoma | Malignant | T1N0M0 | |
A07 |  | F | 26 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
A08 |  | F | 20 | Ovary | Serous cystadenocarcinoma | Malignant | I~II | T1N0M0 |
A09 |  | F | 34 | Ovary | Serous cystadenocarcinoma | Malignant | I | T2N0M0 |
A10 |  | F | 29 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
A11 |  | F | 57 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
A12 |  | F | 41 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
A13 |  | F | 30 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
B01 |  | F | 27 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
B02 |  | F | 31 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
B03 |  | F | 50 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
B04 |  | F | 26 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
B05 |  | F | 29 | Ovary | Serous cystadenocarcinoma | Malignant | I | T3N0M0 |
B06 |  | F | 61 | Ovary | Serous cystadenocarcinoma | Malignant | I~II | T3N0M1 |
B07 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | I~II | T3N0M1 |
B08 |  | F | 54 | Ovary | Mucinous cystadenocarcinoma | Malignant | I~II | T1N0M0 |
B09 |  | F | 42 | Ovary | Mucinous cystadenocarcinoma | Malignant | I~II | T1N0M0 |
B10 |  | F | 35 | Ovary | Serous cystadenocarcinoma | Malignant | I~II | T3N0M1 |
B11 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
B12 |  | F | 48 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N0M0 |
B13 |  | F | 54 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N0M0 |
C01 |  | F | 55 | Ovary | Serous cystadenocarcinoma | Malignant | II | T3N0M1 |
C02 |  | F | 72 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N0M0 |
C03 |  | F | 57 | Ovary | Serous cystadenocarcinoma | Malignant | II | T2N0M0 |
C04 |  | F | 51 | Ovary | Serous cystadenocarcinoma | Malignant | II | T2N0M0 |
C05 |  | F | 51 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N0M0 |
C06 |  | F | 75 | Ovary | Serous cystadenocarcinoma | Malignant | II | T2N0M0 |
C07 |  | F | 65 | Ovary | Endometrioid adenocarcinoma | Malignant | II~III | T1N0M0 |
C08 |  | F | 42 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T2N0M0 |
C09 |  | F | 42 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
C10 |  | F | 54 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N1M1 |
C11 |  | F | 51 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
C12 |  | F | 51 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N1M1 |
C13 |  | F | 45 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
D01 |  | F | 50 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
D02 |  | F | 39 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
D03 |  | F | 74 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
D04 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M1 |
D05 |  | F | 54 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M1 |
D06 |  | F | 60 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
D07 |  | F | 71 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M1 |
D08 |  | F | 50 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M1 |
D09 |  | F | 53 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
D10 |  | F | 52 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
D11 |  | F | 58 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
D12 |  | F | 50 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
D13 |  | F | 59 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M1 |
E01 |  | F | 46 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
E02 |  | F | 40 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N1M1 |
E03 |  | F | 22 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
E04 |  | F | 38 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N1M0 |
E05 |  | F | 18 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
E06 |  | F | 20 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
E07 |  | F | 57 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
E08 |  | F | 76 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
E09 |  | F | 45 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T3N0M1 |
E10 |  | F | 56 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
E11 |  | F | 58 | Ovary | Serous cystadenocarcinoma | Malignant | I~II | T2N0M0 |
E12 |  | F | 44 | Ovary | Mucinous cystadenocarcinoma | Malignant | I~II | T1N0M0 |
E13 |  | F | 66 | Ovary | Mucinous cystadenocarcinoma | Malignant | I~II | T1N0M0 |
F01 |  | F | 65 | Ovary | Serous cystadenocarcinoma | Malignant | I~II | T2N0M0 |
F02 |  | F | 53 | Ovary | Mucinous cystadenocarcinoma | Malignant | II | T1N0M0 |
F03 |  | F | 52 | Ovary | Clear cell carcinoma | Malignant | II | T1N0M0 |
F04 |  | F | 50 | Ovary | Mucinous cystadenocarcinoma | Malignant | II | T2N0M0 |
F05 |  | F | 46 | Ovary | Mucinous cystadenocarcinoma | Malignant | II | T1N0M0 |
F06 |  | F | 43 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
F07 |  | F | 51 | Ovary | Mucinous cystadenocarcinoma | Malignant | III | T2N0M0 |
F08 |  | F | 44 | Ovary | Endometrioid adenocarcinoma | Malignant | I | T2N0M0 |
F09 |  | F | 82 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
F10 |  | F | 51 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
F11 |  | F | 44 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
F12 |  | F | 43 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T3N0M0 |
F13 |  | F | 62 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
G01 |  | F | 59 | Ovary | Serous cystadenocarcinoma | Malignant | II | T3N0M1 |
G02 |  | F | 53 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
G03 |  | F | 44 | Ovary | Endometrioid adenocarcinoma | Malignant | II~III | T1N0M0 |
G04 |  | F | 66 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T1N0M0 |
G05 |  | F | 42 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
G06 |  | F | 51 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
G07 |  | F | 48 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
G08 |  | F | 43 | Ovary | Mucinous cystadenocarcinoma | Malignant | III | T2N0M0 |
G09 |  | F | 54 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
G10 |  | F | 58 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
G11 |  | F | 68 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N1M0 |
G12 |  | F | 49 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
H01 |  | F | 51 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
H02 |  | F | 65 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
H03 |  | F | 51 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
H04 |  | F | 71 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M1 |
H05 |  | F | 58 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M1 |
H06 |  | F | 44 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
H07 |  | F | 41 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
H08 |  | F | 59 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
H09 |  | F | 53 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
H10 |  | F | 65 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N1M1 |
H11 |  | F | 60 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M1 |
H12 |  | F | 57 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M1 |
bottom of page